MiMedx Group Inc (NASDAQ:MDXG) (The Motley Fool)
What happened: Shares of MiMedx Group (NASDAQ:MDXG), a regenerative medicine company, dropped as much as 22% in early morning trading on Monday. As of 11:10 a.m. EST, the stock was down 13%. The fall is tied to a news report today that the company is under investigation by the U.S. Department of Justice. So what: Bloomberg reported on Monday morning that federal authorities are looking into MiMedx’s government sales practices.
Dean Foods Co (NYSE:DF) (MarketWatch)
Dean Foods Co. shares DF, -13.18% slid 10% in premarket trade Monday, after the company missed earnings estimates for the fourth quarter and offered guidance that was below consensus. The company said it had net income of $52.3 million, or 54 cents a share, in the quarter, up from $32.8 million, or 36 cents a share, in the year-earlier period. Adjusted per-share earnings came to 25 cents, below the FactSet consensus of 26 cents. Sales fell to $1.49 billion from $1.52 billion, also below the FactSet consensus of $1.96 billion.
NXT-ID Inc (NASDAQ:NXTD) (Benzinga)
NXT-ID Inc jumped 47.9 percent to $3.22. NXT-ID’s subsidiary FitPay and Discover Financial Services announced plans to extend payments to IoT devices.
GTT Communications Inc (NYSE:GTT) (Barron’s)
GTT Surges on Interoute Buy: Speaking of telecom, shares of network operator GTT Communications (GTT) are up $4, or 8%, at $52, after it announced it will spend €1.9 billion, or roughly $2.3 billion in cash to buy London-based Interoute, one of the largest European operators of fiber-optic network capacity and of data centers. The deal roughly doubles GTT’s size, with Interoute’s $886 million in trailing twelve month revenue comparable to the $715 million that GTT made last year.